GNPXVSSLS• 28 Days (Normalized)
GNPX vs SLS (Genprex Inc. vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Aug, 18 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GNPX Performance $3.31
-16.2%
Genprex Inc.
Normalized Baseline0.00%
SLS Performance $11.29
-13.82%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin SLS LEADS
-2.38%
SLS outperforming by 2.38%
GNPXSLS
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GNPX SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | GNPX Price | GNPX Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $3.31 | -16.20% | $11.29 | -13.82% | -2.38% |
| Sep 14, 2026 | $3.45 | -12.66% | $11.73 | -10.46% | -2.20% |
| Sep 11, 2026 | $3.35 | -15.19% | $11.55 | -11.83% | -3.36% |
| Sep 10, 2026 | $3.35 | -15.19% | $13.49 | +2.98% | -18.17% |
| Sep 09, 2026 | $3.43 | -13.16% | $13.95 | +6.49% | -19.65% |
| Sep 08, 2026 | $3.54 | -10.38% | $13.96 | +6.56% | -16.94% |
| Sep 04, 2026 | $3.50 | -11.39% | $13.86 | +5.80% | -17.19% |
| Sep 03, 2026 | $3.43 | -13.29% | $13.70 | +4.58% | -17.87% |
| Sep 02, 2026 | $3.51 | -11.14% | $14.16 | +8.09% | -19.23% |
| Sep 01, 2026 | $3.55 | -10.13% | $13.22 | +0.92% | -11.05% |
| Aug 31, 2026 | $3.71 | -6.08% | $13.34 | +1.83% | -7.91% |
| Aug 28, 2026 | $3.67 | -7.09% | $13.21 | +0.84% | -7.93% |
| Aug 27, 2026 | $3.61 | -8.61% | $15.21 | +16.11% | -24.72% |
| Aug 26, 2026 | $3.97 | +0.51% | $13.73 | +4.81% | -4.30% |
| Aug 25, 2026 | $4.00 | +1.27% | $14.09 | +7.56% | -6.29% |
Page 1 of 2